Indoco Remedies Limited

NSE: INDOCO · Unclassified

₹215.06+0.16%06 Nov 2026

Ask the data

Instant answers about Indoco Remedies Limited — computed from its filings, no language model

Market cap₹1,985 cr

Current price₹215.06

High / Low₹281 / ₹164

P/E62.1

P/B1.94

Book value₹110.7

ROE3.1%

ROCE8.6%

Debt / equity0.96

Dividend yield0.10%

EPS (TTM)₹3.46

Face value₹2

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 7 periods

	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	1,107	1,242	1,541	1,669	1,817	1,665	1,845
EBITDA	123	224	327	286	244	99	142
Operating margin	11.1%	18.1%	21.2%	17.1%	13.4%	6.0%	7.7%
Interest	26	22	14	25	38	66	122
Depreciation	71	73	79	71	92	114	126
Profit before tax	29	132	237	193	136	-74	-107
Tax	4	39	82	51	39	4	-8
Net profit	24	0	155	142	98	-74	-95
EPS ₹	2.62	10.10	16.80	15.44	10.53	8.46	-10.70
Operating cash flow	—	—	174	179	157	95	192
Capex	—	—	125	207	427	356	148
Dividend paid	—	—	14	21	21	14	2
Total assets	—	—	—	1,658	2,145	2,430	2,593
Equity	—	—	—	1,028	1,110	1,022	939

Quarterly performance

last 29 quarters · ₹ crore

showing latest 8 of 29 periods

	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	293	289	272	276	328	332	305	387	387	358	409	408	433	399	428	426	482	459	450	431	433	411	390	438	485	445	476	468	520
Operating profit	33	35	33	49	61	60	55	87	86	73	81	71	88	62	65	61	71	63	49	48	40	12	-1	18	43	32	50	41	46
Operating margin	11.2%	12.1%	12.2%	17.6%	18.5%	18.1%	17.9%	22.5%	22.3%	20.5%	19.7%	17.5%	20.3%	15.5%	15.1%	14.3%	14.8%	13.7%	10.9%	11.1%	9.3%	2.9%	-0.2%	4.0%	8.9%	7.1%	10.5%	8.8%	8.9%
Other income	1	1	0	0	1	0	2	1	1	0	0	1	0	0	0	0	4	2	3	1	2	1	2	2	1	1	-0	2	2
Interest	5	7	8	6	6	6	5	4	3	4	3	4	5	7	9	8	8	10	12	14	18	16	18	26	25	26	46	28	27
Depreciation	18	18	18	19	19	17	19	22	19	19	18	20	16	17	18	20	21	24	26	28	29	29	29	30	32	32	32	35	34
Profit before tax	10	11	8	24	37	38	34	61	65	51	60	48	67	38	39	34	46	23	33	7	-5	-31	-46	-37	-14	-31	-25	78	24
Tax	2	2	2	7	11	12	9	22	23	18	19	10	18	10	13	10	11	7	11	5	5	-3	-4	-0	-4	-2	-1	12	5
Net profit	8	0	5	0	26	25	0	40	0	33	40	-1	50	28	26	24	35	16	23	3	-10	-26	-40	-36	-8	-30	-22	65	18
EPS ₹	0.85	0.99	0.58	1.85	2.78	2.75	2.71	4.30	4.52	3.58	4.39	4.19	5.40	3.05	2.80	2.62	3.82	1.69	2.39	0.20	-1.09	-3.08	-4.48	-3.94	-1.00	-3.20	-2.57	7.09	2.11
Revenue YoY	—	—	—	—	12.2%	14.8%	12.2%	40.2%	17.9%	7.7%	34.1%	5.6%	11.9%	11.5%	4.7%	4.5%	11.2%	15.1%	5.0%	1.2%	-10.2%	-10.6%	-13.2%	1.5%	12.0%	8.5%	21.9%	6.8%	7.3%
Profit YoY	—	—	—	—	228.4%	—	-100.0%	—	-100.0%	30.1%	—	-102.5%	—	-14.7%	-36.2%	—	-29.5%	-42.1%	-12.0%	-89.3%	-127.3%	-261.9%	-277.9%	-1466.0%	—	—	—	—	—

Earlier results (standalone, Sep '07 – Jun '19)

₹ crore · from BSE, before the NSE XBRL filings begin

Indoco Remedies Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 11 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†
Revenue	354	403	487	564	630	728	854	1,000	1,094	1,042	968
Operating profit	49	58	72	77	93	120	165	172	159	135	77
Operating margin	13.8%	14.4%	14.9%	13.6%	14.8%	16.5%	19.4%	17.2%	14.5%	12.9%	7.9%
Other income	1	0	—	—	1	2	2	1	4	5	6
Interest	6	3	2	7	22	19	10	12	8	24	21
Depreciation	11	12	13	19	24	31	47	60	63	68	72
Profit before tax	33	43	57	51	48	72	109	101	91	48	-9
Tax	2	1	5	5	6	14	27	18	14	7	-6
Net profit	31	42	51	46	43	58	83	83	77	41	-3

Quarters

showing latest 8 of 48 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†	JUN '19†
Revenue	84	91	87	109	79	79	86	101	96	96	110	113	135	115	123	127	147	143	147	156	162	153	159	154	202	188	184	199	228	217	210	223	255	259	263	257	281	278	277	209	285	278	270	218	236	263	252	253
Operating profit	16	16	10	28	7	6	8	21	13	11	13	19	21	14	18	19	21	16	21	26	23	19	25	24	33	30	33	37	49	43	37	43	46	43	41	42	42	40	36	1	41	43	49	12	12	25	29	23
Operating margin	19.0%	18.0%	11.1%	25.8%	8.3%	7.6%	9.4%	20.8%	13.6%	11.9%	11.4%	16.9%	15.4%	12.5%	14.6%	14.6%	14.0%	11.4%	14.5%	16.4%	14.1%	12.5%	16.0%	15.8%	16.3%	15.9%	17.9%	18.4%	21.3%	19.7%	17.8%	19.1%	17.9%	16.7%	15.5%	16.2%	14.9%	14.2%	12.9%	0.6%	14.4%	15.5%	18.3%	5.3%	5.0%	9.4%	11.3%	9.0%
Other income	1	2	1	1	0	0	0	0	0	0	0	—	0	0	0	—	0	—	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	1	0	1	1	2	1	2	1	1	0	0	1	5	1
Interest	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	2	3	8	4	5	5	6	5	4	3	3	3	3	2	2	3	3	5	2	2	3	2	6	7	2	8	7	5	4	5	6
Depreciation	3	3	3	3	3	3	3	3	3	3	3	3	3	3	3	4	5	5	5	6	6	6	6	7	8	8	8	9	13	12	13	15	15	15	15	17	17	14	15	17	17	17	16	17	18	18	19	17
Profit before tax	13	14	6	25	3	1	4	17	10	8	9	15	17	10	14	14	15	9	14	12	13	9	14	11	20	18	23	25	33	28	23	26	29	25	21	23	25	23	20	-21	19	24	26	-12	-11	4	9	0
Tax	2	3	-1	0	1	1	-0	0	0	0	0	0	2	2	2	2	1	1	1	1	1	2	1	2	4	4	4	5	11	7	4	5	6	5	1	3	3	6	2	1	-1	2	5	0	-3	-1	-2	-2
Net profit	11	12	7	25	2	1	4	17	9	8	8	15	15	9	12	12	14	8	13	10	12	7	13	9	16	14	19	20	22	22	19	20	23	20	20	20	22	18	18	-22	20	23	20	-12	-8	5	12	2
EPS ₹	8.83	9.64	5.95	20.02	1.77	0.51	3.19	13.74	7.53	6.29	6.70	12.06	12.42	7.17	9.90	9.56	11.24	6.72	1.36	1.12	1.31	0.80	1.39	1.00	1.74	1.53	2.01	2.17	2.43	2.35	2.03	2.20	2.45	2.22	2.17	2.15	2.40	1.91	1.95	-2.36	2.14	2.46	2.22	-1.30	-0.85	0.58	1.26	0.24
Revenue YoY	—	—	—	—	-6.0%	-13.9%	-0.8%	-8.1%	21.2%	22.2%	27.8%	12.2%	40.9%	20.4%	11.2%	12.6%	8.8%	23.5%	20.0%	22.8%	9.9%	7.5%	7.9%	-1.4%	24.9%	22.5%	15.5%	29.0%	12.9%	15.4%	14.3%	12.5%	11.6%	19.4%	25.5%	15.2%	10.2%	7.6%	5.1%	-18.8%	1.4%	-0.0%	-2.6%	4.1%	-17.3%	-5.6%	-6.5%	16.2%
Profit YoY	—	—	—	—	-80.0%	-94.7%	-46.4%	-31.4%	326.3%	1127.0%	109.9%	-12.2%	65.0%	14.0%	47.8%	-20.8%	-9.5%	-6.2%	3.0%	-11.8%	-12.5%	-10.7%	2.6%	-11.3%	32.8%	91.3%	44.4%	118.3%	39.7%	53.1%	1.1%	1.1%	0.9%	-5.6%	6.7%	-2.4%	-2.2%	-13.9%	-10.3%	-209.8%	-10.7%	28.6%	14.3%	—	-139.4%	-76.4%	-43.3%	—

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 26 periods

	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	—	—	—	—	12.6%	12.1%	10.0%	12.5%	10.6%	9.5%	8.9%	6.9%	2.9%	-1.0%	-7.2%	-11.0%	-11.3%	-11.6%	-10.1%	0.6%	3.1%
ROCE	—	—	—	—	—	—	—	—	—	19.3%	18.5%	16.0%	15.2%	12.1%	11.3%	9.8%	8.6%	5.8%	3.3%	-0.4%	-2.0%	-2.1%	-1.7%	0.8%	6.7%	8.6%
Net margin	1.2%	2.7%	4.7%	4.1%	6.7%	4.6%	5.1%	7.3%	4.6%	7.6%	7.1%	6.2%	7.6%	6.5%	5.7%	5.4%	4.2%	1.8%	-0.6%	-4.4%	-6.7%	-6.4%	-6.5%	-5.2%	0.3%	1.7%
EBITDA margin	13.2%	15.2%	16.8%	18.1%	19.4%	20.4%	21.0%	21.2%	20.0%	19.5%	18.3%	17.1%	16.4%	14.9%	14.5%	13.4%	12.7%	11.3%	8.6%	6.0%	4.1%	4.2%	5.2%	7.7%	8.8%	8.8%
Debt / equity	—	—	—	—	—	—	—	—	—	0.30	0.30	0.32	0.32	0.46	0.46	0.61	0.61	0.77	0.77	0.97	0.97	1.02	1.02	1.10	1.10	0.96
Interest coverage	3.03	4.02	5.16	6.93	9.16	12.02	14.41	17.73	16.94	14.92	11.99	8.70	7.22	5.99	5.10	4.57	3.44	2.06	1.07	-0.12	-0.51	-0.49	-0.35	0.13	1.06	1.36
Asset turnover	—	—	—	—	—	—	—	—	—	0.97	0.99	1.01	1.02	0.90	0.93	0.85	0.85	0.74	0.72	0.69	0.69	0.69	0.70	0.71	0.72	0.73

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	18	18	18	18	18	18	18	18	18
Other equity / reserves	952	1,010	1,050	1,091	1,071	1,004	961	921	1,003
Total equity	970	1,028	1,068	1,110	1,090	1,022	980	939	1,022
Borrowings	287	333	496	672	834	994	999	1,036	976
Current liabilities	536	425	568	612	801	808	985	1,053	972
Non-current liabilities	159	205	299	422	500	604	549	609	625
Total assets	1,665	1,658	1,938	2,145	2,390	2,430	2,508	2,593	2,613
Property, plant & equipment	548	612	613	788	797	849	949	970	929
Capital work-in-progress	74	55	93	103	230	276	182	28	27
Investments	0	2	5	9	14	1	1	1	15
Inventories	347	326	355	353	383	419	425	405	397
Receivables	346	351	405	406	382	352	453	489	538
Cash & equivalents	18	11	61	15	18	12	13	26	35

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	174	179	157	95	192
Cash from investing	-121	-208	-434	-339	-102
Cash from financing	-44	23	280	241	-77
Capex	125	207	427	356	148
Free cash flow	49	-28	-271	-261	45
Dividends paid	14	21	21	14	2

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹929 cr36%

CWIP

₹27 cr1%

Investments

₹15 cr1%

Inventories

₹397 cr15%

Receivables

₹538 cr21%

Cash & equivalents

₹35 cr1%

Other assets

₹672 cr26%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Indoco Remedies Limited	1,985	215.06	62.1	1.94	3.1%

StoxGud checklist: Bearish setup · 3/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-12.8%

6 months-14.2%

1 year-21.9%

3Y CAGR-12.8%

5Y CAGR-13.7%

10Y CAGR-2.6%

50-day avg₹240.37

200-day avg₹222.10

RSI (14)21

FAQs

What is the share price of Indoco Remedies Limited?

Indoco Remedies Limited (INDOCO) closed at ₹215.06 on NSE on 06 Nov 2026.

What is the market cap of Indoco Remedies Limited?

₹1,985 crore at the latest close.

What is the P/E ratio of Indoco Remedies Limited?

62.1, on trailing-twelve-month earnings from its filings.

How fast is Indoco Remedies Limited growing?

Indoco Remedies Limited: revenue has compounded at 3.4% a year over three years. Latest-quarter revenue is up 7.3% year on year.

How profitable is Indoco Remedies Limited?

On a trailing-twelve-month basis return on equity is 3.1%, return on capital employed 8.6%, operating margin 8.8%, net margin 1.7%.

How much debt does Indoco Remedies Limited have?

Indoco Remedies Limited is moderately geared: debt to equity is 0.96 with borrowings of ₹976 cr against cash of ₹35 cr (balance sheet of 2026-09-30). Operating profit covers interest 1.4 times.

Financials parsed from Indoco Remedies Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '19, annual from FY20, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.